In-gel activity-based protein profiling of a clickable covalent ERK1/2 inhibitor

被引:16
|
作者
Lebraud, Honorine [1 ]
Wright, David J. [1 ]
East, Charlotte E. [1 ]
Holding, Finn P. [1 ]
O'Reilly, Marc [1 ]
Heightman, Tom D. [1 ]
机构
[1] Astex Pharmaceut, 436 Cambridge Sci Pk, Cambridge CB4 0QA, England
关键词
CHEMICAL PROBES; LIVING CELLS; LIVE CELLS; DISCOVERY; KINASE; TETRAZINE; SELECTIVITY; CHEMISTRY; MECHANISM; LIGATION;
D O I
10.1039/c6mb00367b
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In-gel activity-based protein profiling (ABPP) offers rapid assessment of the proteome-wide selectivity and target engagement of a chemical tool. Here we demonstrate the use of the inverse electron demand Diels Alder (IEDDA) click reaction for in-gel ABPP by evaluating the selectivity profile and target engagement of a covalent ERK1/2 probe tagged with a trans-cyclooctene group. The chemical probe was shown to bind covalently to Cys166 of ERK2 using protein MS and X-ray crystallography, and displayed submicromolar GI(50)s in A375 and HCT116 cells. In both cell lines, the probe demonstrated target engagement and a good selectivity profile at low concentrations, which was lost at higher concentrations. The IEDDA cycloaddition enabled fast and quantitative fluorescent tagging for readout with a high background-to-noise ratio and thereby provides a promising alternative to the commonly used copper catalysed alkyne-azide cycloaddition.
引用
收藏
页码:2867 / 2874
页数:8
相关论文
共 50 条
  • [1] Development of a clickable activity-based protein profiling (ABPP) probe for agmatine deiminases
    Marchenko, Mikhail
    Thomson, Andrew
    Ellis, Terri N.
    Knuckley, Bryan
    Causey, Corey P.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (09) : 2159 - 2167
  • [2] Enzyme Inhibitor Discovery by Activity-Based Protein Profiling
    Niphakis, Micah J.
    Cravatt, Benjamin F.
    ANNUAL REVIEW OF BIOCHEMISTRY, VOL 83, 2014, 83 : 341 - 377
  • [3] Discovery of CC-90003: A covalent ERK1/2 inhibitor
    Qiao, Li-Xin
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [4] Activity-based Protein Profiling
    Wang Chu
    Chen Nan
    ACTA CHIMICA SINICA, 2015, 73 (07) : 657 - 668
  • [5] Characterization of a novel ERK1/2 inhibitor, which modulates the phosphorylation and catalytic activity of ERK1/2
    Munck, Joanne M.
    Berdini, Valerio
    Bevan, Luke D.
    Braithwaite, Hannah
    Buck, Ildiko M.
    Cassidy, Megan
    Castro, Juan
    Courtin, Aurelie
    Day, James E.
    East, Charlotte
    Fazal, Lynsey
    Graham, Brent
    Griffiths-Jones, Charlotte M.
    Heightman, Tom D.
    Hindley, Chris J.
    Kidane, Birikiti
    Kucia-Tran, Justyna
    Lyons, John F.
    Martins, Vanessa
    Muench, Sandra
    Murray, Chris W.
    Norton, David
    O'Reilly, Marc
    Palmer, Nick
    Pathuri, Puja
    Reader, Mike
    Rees, David C.
    Rich, Sharna J.
    Richardson, Caroline J.
    Saini, Harpreet K.
    Shah, Alpesh
    Stanczuk, Lukas
    Thompson, Neil T.
    Walton, Hugh
    Wilsher, Nicola E.
    Woolford, Alison J.
    Wallis, Nicola G.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [6] Activity-Based Protein Profiling of Protein Arginine Methyltransferase 1
    Obianyo, Obiamaka
    Causey, Corey P.
    Jones, Justin E.
    Thompson, Paul R.
    ACS CHEMICAL BIOLOGY, 2011, 6 (10) : 1127 - 1135
  • [7] Activity-Based Protein Profiling Preface
    Sieber, Stephan
    Nodwell, Matthew
    ACTIVITY-BASED PROTEIN PROFILING, 2012, 324 : IX - X
  • [8] Activity-based protein profiling of microbes
    Sadler, Natalie C.
    Wright, Aaron T.
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2015, 24 : 139 - 144
  • [9] Activity-Based Protein Profiling Preface
    Cravatt, Benjamin F.
    Hsu, Ku-Lung
    Weerapana, Eranthie
    ACTIVITY-BASED PROTEIN PROFILING, 2019, 420 : V - VII
  • [10] Fragment-based discovery of a highly potent, orally bioavailable ERK1/2 inhibitor that modulates the phosphorylation and catalytic activity of ERK1/2
    Heightman, Tom D.
    Berdini, Valerio
    Braithwaite, Hannah
    Buck, Ildiko
    Cassidy, Megan
    Castro, Juan
    Courtin, Aurelie
    Day, James
    East, Charlotte
    Fazal, Lynsey
    Graham, Brent
    Griffiths-Jones, Charlotte
    Lyons, John
    Martins, Vanessa
    Muench, Sandra
    Munck, Joanne
    Norton, David
    O'Reilly, Marc
    Palmer, Nick
    Pathuri, Puja
    Reader, Mike
    Rees, David
    Rich, Sharna
    Richardson, Caroline
    Saini, Harpreet
    Thompson, Neil
    Wallis, Nicola
    Walton, Hugh
    Wilsher, Nicola
    Woolford, Alison
    Murray, Chris
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)